TuHURA Biosciences (HURA) Enterprise Value (2010 - 2026)

TuHURA Biosciences' Enterprise Value history runs 17 years deep, the most recent figure standing at -$6.3 million for Q1 2026.

• On a quarterly basis, Enterprise Value fell 1.29% year-over-year to -$6.3 million in Q1 2026; TTM through Mar 2026 was -$6.3 million, a 1.29% decrease from a year earlier, with the FY2025 full-year figure at -$3.6 million, up 71.4% from the prior year.
• Enterprise Value eased to -$6.3 million in Q1 2026 per HURA's latest filing, from -$3.6 million in the prior quarter.
• Across five years, Enterprise Value topped out at -$216000.0 in Q3 2023 and bottomed at -$12.7 million in Q4 2024.
• The 5-year median for Enterprise Value is -$4.9 million (2024), against an average of -$5.6 million.
• Across the five-year window, Enterprise Value jumped 96.95% in 2023 and plunged 1298.15% in 2024, its largest moves.
• Year by year, Enterprise Value stood at -$4.9 million in 2022, then grew by 24.8% to -$3.7 million in 2023, then sank by 245.35% to -$12.7 million in 2024, then surged by 71.4% to -$3.6 million in 2025, then tumbled by 74.04% to -$6.3 million in 2026.
• Per Business Quant, the three latest HURA Enterprise Value figures stand at -$6.3 million (Q1 2026), -$3.6 million (Q4 2025), and -$2.7 million (Q3 2025).